Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
4 clinical trials · Condition
◉ Watch Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
| Record | Firm | Date |
|---|---|---|
| Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001 (NCT05697861) | Intellia Therapeutics | 2023-07-10 |
| Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers (NCT05489549) | University of Texas Southwestern Medical Center | 2022-11-21 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM) (NCT04601051) | Intellia Therapeutics | 2020-11-05 |
| TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects (NCT03237494) | CENTOGENE GmbH Rostock | 2017-07-20 |
Track Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy automatically
Every clearance here is in the API, with alerts when new ones post.